Cost-effectiveness Analysis of Three Therapeutic Schemes for Hp Infection
- VernacularTitle:3种方案治疗幽门螺旋杆菌感染的成本-效果分析
- Author:
Bangsheng ZHANG
;
Jian SHEN
;
Yanzhi ZHOU
;
Guiqing BAO
- Publication Type:Journal Article
- Keywords:
Hp(helicobacteria pylori);
therapeutic scheme;
cost-effectiveness analysis
- From:
China Pharmacy
2001;0(10):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the economic effectiveness of different pharmacotherapeutic schemes for peptic ulcer and chronic gastritis with infection of Helicobacteria pylori(Hp) METHODS:To perform cost-effectiveness analysis of three ther_apeutic schemes for Hp infection RESULTS:The cost-effectiveness ratios of three therapeutic schemes were 8 71,10 12 and 13 99 CONCLUSION:Scheme A(omeprazole+amoxicillin+clarithomycin) is the best one